3

SEC Filing Details

Document Details

Form
Filing Date
Apr 2, 2019
Document Date
Mar 15, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
ContraVir Pharmaceuticals
Issuer
ContraVir Pharmaceuticals, Inc.
Filer
Garlikov Donald E